Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2010
05/06/2010US20100113467 Organic Compounds
05/06/2010US20100113446 Hydantoin compounds
05/06/2010US20100113442 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
05/06/2010US20100113429 Inhibitors of ftsz and uses thereof
05/06/2010US20100113428 Diazabicyclic aryl derivatives as cholinergic receptor modulators
05/06/2010US20100113415 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
05/06/2010US20100113412 IMIDAZO[1,2-a]PYRIDINES AND THEIR USE AS PHARMACEUTICALS
05/06/2010US20100113411 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
05/06/2010US20100112090 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
05/06/2010US20100108990 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same
05/06/2010US20100108959 Materials and methods for the preparation of anisotropically-ordered solids
05/06/2010CA2779261A1 Filamin a binding anti-inflammatory and analgesic
05/06/2010CA2779252A1 Filamin a-binding anti-inflammatory analgesic
05/06/2010CA2742322A1 Azepino[4,5-b]indoles and methods of use
05/06/2010CA2742320A1 Pyrido[4,3-b]indoles containing rigid moieties
05/06/2010CA2741783A1 Compounds having tafia inhibitory activity
05/06/2010CA2741153A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010CA2741138A1 Substituted pyridines having herbicidal action
05/05/2010EP2181997A1 A process for the preparation of tadalafil
05/05/2010EP2181996A1 Aminopiperidine derivatives
05/05/2010EP2181994A1 Antimicrobial compounds
05/05/2010EP2181993A1 Antimicrobial oxazolidinone derivatives
05/05/2010EP2181992A1 Polycyclic compound
05/05/2010EP2181112A1 Triazolopyridine compounds and their use as ask inhibitors
05/05/2010EP2181108A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
05/05/2010EP2181096A1 Use of rylene derivatives as active components in solar cells and photodetectors
05/05/2010EP2102204B1 New aminopyrrolo[1,2- a]indole et aminopyridazino[1,6-a]indole derivatives, method for preparing the same and pharmaceutical compositions containing the same
05/05/2010EP1485100B1 Azinylaminoazoles as inhibitors of protein kinases
05/05/2010EP1474147B1 Pyrimidine-based compounds useful as gsk-3 inhibitors
05/05/2010EP1167366B1 Amine derivatives
05/05/2010CN1878767B Azole-based kinase inhibitors
05/05/2010CN101701024A Ruthenium complex, preparation method thereof and application thereof
05/05/2010CN101039944B 1,5-naphthyridine azolidinones having CDK1 antiproliferative activity
05/04/2010US7709645 to treat diseases mediated by kinase activity; for example: leukemia or myeloproliferative disorder; 5-bromo-3-[4-(tetrahydro-pyran-2-yloxy)-phenyl]-1-(toluene-4-sulfonyl)-1H-pyrrolo[2,3-b]pyridine
05/04/2010US7709644 enantiomeric enrichment of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane with the aid of continuous countercurrent chromatography, nuclear hydrogenation of pyridine-2,3-dicarboxylic acid-N-benzylimide
05/04/2010US7709642 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
05/04/2010US7709637 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi
05/04/2010US7709500 Chemical compounds
05/04/2010US7709497 Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor
05/04/2010US7709495 Methods and reagents for the treatment of inflammatory disorders
05/04/2010US7709489 e.g. 1-(9-Benzylamino-10-cyano-imidazo[1,2-a]quinoline-2-carbonyl)-4-methylpiperazine; cardiovascular diseases; acylation of imidazo[1,2- alpha]quinoline acid derivatives by morpholine derivatives
05/04/2010US7709488 2-[2-(4-Methoxypyridin-2-yl)ethyl]-6-[4-(4-methylpiperazin-1-yl-sulfonyl)-phenyl]-3H-imidazo-[4,5-b]pyridine,; acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, organ transplantation and transplant rejection, head trauma, acute lung injury
05/04/2010US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides
05/04/2010US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010US7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals
05/04/2010CA2518081C New process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate
05/04/2010CA2492540C Modified pictet-spengler reaction and products prepared therefrom
05/04/2010CA2453609C Bridged piperidine derivatives as melanocortin receptor agonists
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
05/04/2010CA2414200C Variolin derivatives as anti-cancer agents
04/2010
04/29/2010WO2010048314A1 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
04/29/2010WO2010048191A1 Thioamide compounds, method of making and method of using thereof
04/29/2010WO2010047369A1 Agent for treatment of diabetic nephropathy
04/29/2010WO2010047279A1 Organic electroluminescent element
04/29/2010WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT
04/29/2010WO2010046851A1 Process for the preparation of 1- ( 3-hydroxymethylpyrid-2 -yl ) -2 -phenyl-4-methylpiperazine and mirtazapine
04/29/2010WO2010046791A1 Phosphodiestarase inhibitors
04/29/2010WO2010046780A2 Anti viral compounds
04/29/2010WO2010046388A1 Substituted (aza) -1-methyl-1h-quinolin-2-ones as antibacterials
04/29/2010WO2010046109A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain
04/29/2010WO2010046013A1 Azaindole derivative
04/29/2010WO2010045987A1 Substituted (aza) -1-methyl-1h-quin0lin-2-0nes as antibacterials
04/29/2010WO2010011772A3 Tri-cyclic pyrazolopyridine kinase inhibitors
04/29/2010WO2010007316A3 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
04/29/2010WO2010003475A3 Novel pyrrolidone derivatives for use as metap-2 inhibitors
04/29/2010WO2009026446A8 Hdac inhibitors
04/29/2010US20100105915 Chemokine receptor binding heterocyclic compounds
04/29/2010US20100105912 FLUORO-CONTAINING DERIVATIVES OF HYDROGENATED PYRIDO[4,3-b]INDOLES WITH NEUROPROTECTIVE AND COGNITION ENHANCING PROPERTIES, PROCESS FOR PREPARING, AND USE
04/29/2010US20100105894 Cyclopropane compounds and pharmaceutical use thereof
04/29/2010US20100105723 5-PHENYL-6-PYRIDIN-4-YL-1,3-DIHYDRO-2H-IMIDAZO[4,5-b]PYRIDIN-2-ONE DERIVATIVES USEFUL AS A2B ADENOSINE RECEPTOR ANTAGONISTS
04/29/2010US20100105719 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
04/29/2010US20100105718 Naphthalene and quinoline sulfonylurea derivatives as ep4 receptor antagonists
04/29/2010US20100105714 Furanone Compounds and Methods of Making and Using The Same
04/29/2010US20100105713 GLYT1 Transporter Inhibitors and Uses Thereof in Treatment of Neurological and Neuropsychiatric Disorders
04/29/2010US20100105678 Novel anxiolytic compounds
04/29/2010US20100105661 Condensed pyridine compound
04/29/2010US20100105659 2-aminopyridine analogs as glucokinase activators
04/29/2010US20100105654 Substituted quinazolinone compounds
04/29/2010US20100104659 Benzopyranopyrazoles
04/29/2010DE102008052943A1 Azaindolderivate Azaindole derivatives
04/29/2010CA2741718A1 Modulators of cystic fibrosis transmembrane conductance regulator
04/29/2010CA2741428A1 Azaindole derivatives
04/29/2010CA2741349A1 Pyrimidine and triazine sulfonamide derivates as b1 bradykinin receptor (b1r) inhibitors for treating pain
04/29/2010CA2741313A1 Substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors
04/29/2010CA2741186A1 Thioamide compounds, method of making and method of using thereof
04/29/2010CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient
04/29/2010CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient
04/29/2010CA2738591A1 Berberine compounds and processes for the preparation of berberine compounds
04/29/2010CA2735956A1 Phosphodiestarase inhibitors
04/28/2010EP2179999A1 Fused tricyclic compound having aldose reductase inhibitory activity
04/28/2010EP2178879A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof
04/28/2010EP2178876A1 Spiro condensed barbituric acid derivatives for use as antibacterial
04/28/2010EP2178875A1 Indolopyridines as inhibitors of the kinesin spindle protein (eg5 )
04/28/2010EP2178874A1 Heterocyclic compounds useful as mk2 inhibitors
04/28/2010EP2178873A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors
04/28/2010EP2178872A1 Paliperidone derivatives
04/28/2010EP2178871A2 Cyclic ethers
04/28/2010EP2178868A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 646